AB
Abacus Bioscience
The startup develops immune therapeutic treatments that deliver specific antigens to receptors on immune cells, enhancing protective immunity against cancer and chronic viral diseases. This platform allows healthcare professionals to utilize a versatile system that can be tailored with various cancer or viral antigens for targeted treatment.
- Biotechnology
Updated 5 months ago
Funding
Raised to date
$4.4MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
across 1 round
RoundDateAmountValuationInvestors
Founders
Product
Features
- The startup develops immune therapeutic treatments that deliver specific antigens to receptors on immune cells, enhancing protective immunity against cancer and chronic viral diseases. This platform allows healthcare professionals to utilize a versatile system that can be tailored with various cancer or viral antigens for targeted treatment.